Basic Pan-Cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (CDK4) in Human Surface Tumors

Jingping Wu1, Tinghan Deng2, Yuanen Huang2

  • 1Department of Medical Cosmetology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.

Insights

This study explored the role of CDK4 in various human skin tumors. High CDK4 expression was linked to poorer cancer prognosis, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The role of Cyclin-Dependent Kinase 4 (CDK4) in cancer is known, but a comprehensive pan-cancer analysis in human skin tumors is lacking.
  • Previous research suggests potential links between CDK4 and carcinogenesis, necessitating further investigation.

Purpose of the Study:

  • To conduct a pan-cancer analysis of CDK4 gene expression and its correlation with patient prognosis across 33 human tumors.
  • To investigate the oncogenic effects of CDK4 in human skin tumors, including melanoma and lung adenocarcinoma.

Main Methods:

  • Utilized datasets from Gene Expression Omnibus (GEO) and Cancer Genome Atlas (CGA) for pan-cancer analysis.
  • Examined CDK4 expression levels, patient prognosis, and specific molecular alterations (e.g., r24l/C/h/s phosphorylation) in various tumor types.
  • Assessed fibroblast infiltration associated with CDK4 in specific skin cancers.

Main Results:

  • CDK4 was found to be highly expressed in the majority of analyzed cancers.
  • Elevated CDK4 expression significantly correlated with poorer patient prognosis across multiple cancer types.
  • Increased r24l/C/h/s phosphorylation and fibroblast infiltration were observed in CDK4-associated skin cancers like melanoma and head and neck tumors.

Conclusions:

  • This pan-cancer study provides preliminary evidence for the oncogenic role of CDK4 in diverse human skin tumors.
  • CDK4's high expression and association with poor prognosis highlight its potential as a therapeutic target in skin cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K